Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|June 10, 2022
Curcumin and Related Compounds in Cancer Cells: New Avenues for Old MoleculesMatteo Costantino, Cristina Corno, Diego Colombo, et al.
International Journal of Biological Sciences|October 21, 2024
Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor AggressivenessGiovanni Luca Beretta, Matteo Costantino, Luca Mirra, et al.
Biochemical Pharmacology|April 18, 2022
P301L tau mutation leads to alterations of cell cycle, DNA damage response and apoptosis: Evidence for a role of tau in cancerSara Cimini, Giorgio Giaccone, Fabrizio Tagliavini, et al.
Current Medicinal Chemistry|February 25, 2022
The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug TargetsCristina Maracci, Stefano Motta, Alice Romagnoli, et al.
International Journal of Molecular Sciences|August 12, 2022
Identification of a βCD-Based Hyper-Branched Negatively Charged Polymer as HSV-2 and RSV InhibitorRachele Francese, Claudio Cecone, Matteo Costantino, et al.
Antiviral Research|May 10, 2023
Identification of oxysterol synthetic analogs as a novel class of late-stage inhibitors of herpes simplex virus 2 replicationAndrea Civra, Matteo Costantino, Giulia Ronchi, et al.
Antiviral Research|February 15, 2025
25R,26-hydroxycholesterol and an oxysterol synthetic analog inhibit Varicella zoster Virus replicationAndrea Civra, Matteo Costantino, Domiziana Porporato, et al.
Molecular Pharmaceutics|March 20, 2026
Lipid Nanoparticle-Mediated Delivery of 27-Hydroxycholesterol for Targeting Rhinovirus-Induced Respiratory DiseasesMathieu Repellin, Matteo Costantino, Rachele Francese, et al.
Bioorganic Chemistry|November 1, 2024
Cholenamide-based, antiviral fluorescent probes targeting oxysterol-binding proteinFatima Nigro, Andrea Civra, Domiziana Porporato, et al.
Pageof 2